Loading...
XHKG
2219
Market cap236mUSD
Dec 05, Last price  
2.66HKD
1D
0.38%
1Q
-2.56%
IPO
-83.92%
Name

Chaoju Eye Care Holdings Ltd

Chart & Performance

D1W1MN
XHKG:2219 chart
P/E
8.56
P/S
1.19
EPS
0.28
Div Yield, %
7.80%
Shrs. gr., 5y
0.11%
Rev. gr., 5y
14.48%
Revenues
1.41b
+2.62%
632,659,000714,671,000794,282,000997,787,000990,044,0001,369,505,0001,405,454,000
Net income
195m
-14.78%
38,709,00075,651,000124,139,000161,749,000187,752,000228,914,000195,076,000
CFO
354m
-4.89%
90,433,000155,887,000248,745,000249,394,000273,410,000372,569,000354,355,000
Dividend
Jun 10, 20250.1193 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.
IPO date
Jul 07, 2021
Employees
2,389
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT